Radioactive bead therapy for liver cancer
Part of Cancer, Digestive system clinical trials.
This trial tests a treatment using tiny radioactive beads (TheraSphere) to target and destroy liver tumors in people with early-stage liver cancer. It aims to confirm the safety and effectiveness of a new way to plan the treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have liver cancer that cannot be surgically removed, but it has not spread beyond the liver or into major blood vessels.
- You have not had any prior treatment for your liver cancer.
- You are in generally good health (able to care for yourself, up and about).
- Your liver, kidney, and blood function are within acceptable levels.
- If you can become pregnant, you must have a negative pregnancy test and use effective birth control.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a treatment that delivers tiny radioactive beads directly to liver tumors to shrink them, which may help patients become eligible for a liver transplant or surgery. It is for people with liver cancer that has not spread outside the liver.
This trial tests a targeted internal radiation treatment for people with liver cancer (HCC) that is too widespread for surgery and goes beyond the up-to-7 criteria. It aims to see if this therapy can safely and effectively treat tumors that are all located in a specific area of the liver.
This trial tests a treatment called radioembolization for small liver cancers. Radioembolization delivers tiny radioactive beads to the tumor, and the goal is to see if it helps shrink or control the cancer.
This study looks at how patients with liver cancer (HCC) respond to a treatment called SIR-Spheres, which are tiny radioactive beads placed in the liver. It is for people who received this treatment in 2023 or early 2024 and were checked for tumor response within six months after treatment.
This trial is testing a low 'scout' dose of tiny radioactive beads (resin microspheres) given into the liver to treat liver cancer. The goal is to see if this approach is safe and helps patients with certain types of liver cancer that cannot be surgically removed.
This trial tests two different ways to treat liver cancer that can't be removed with surgery. It compares stereotactic body radiation therapy (targeted high-dose radiation) with selective internal radiation therapy (tiny radioactive beads delivered through a blood vessel), both combined with immunotherapy (medicines that help your immune system fight cancer).
Hear when a new Hepatocellular Carcinoma (HCC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.